echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Chinese scientists have developed an mRNA vaccine that can be effectively protected in one dose

    Chinese scientists have developed an mRNA vaccine that can be effectively protected in one dose

    • Last Update: 2021-02-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    February 6, Science and Technology Daily reporter from Shanxi Institute of Advanced Innovation was informed that the Institute and
    Institute of Microbiology Yan Jinghua, Gao Fu and China CDC Tan Wenjie developed mRNA vaccine, a dose can be effectively protected. There is no need for the current two-dose vaccination programme.
    results were published in the February 3, 2021 issue of TheNature Communications, a sub-issue. Entitled: A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic from from SARS-CoV-2.
    , the team developed a nucleoside-modified mRNA vaccine wrapped in lipid nanoparticles (LNP), which encodes the new coronavirus S protein RBD domain (mRNA-RBD).
    test results show that the single dose of the mRNA vaccine developed by Chinese scientists can cause strong antibody and cellular immune response, and provide near-complete protection for hACE2 genetically modified mice against wild new coronavirus infection. Further studies have shown that the mRNA vaccine induces high levels of meso-antibodies that last at least 6.5 months. These data suggest that the mRNA vaccine provides long-term protection against the new coronavirus in hACE2 genetically modified mice with a single dose.
    since there is still no effective treatment for neo-crown pneumonia, vaccination is the most effective measure to prevent and stop the new crown pandemic.
    The nucleoside-modified mRNA vaccine, developed by the research team, is enough to induce a strong antibody and cellular immune response with a single dose, providing near-complete long-term protection against wild neo-coronavirus infections in hACE2 genetically modified mice.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.